Singular Genomics AACR 2024 Presentation by Eli Glezer, PhD | In-Situ Sequencing

In-situ multiomics is revolutionizing research in oncology, immunology and neurobiology. However, speed and throughput are major bottlenecks for these critical studies. At the American Association for Cancer Research (AACR) Annual Meeting 2024, our CSO and Co-founder, Eli Glezer, PhD., presented data from G4X, a novel in-situ sequencing system, with sub-micron resolution and ultra-high throughput capacity, employing rapid 4-color SBS chemistry to profile RNA transcripts and proteins in FFPE tissue. The platform also generates virtual H&E images, producing multi-modal spatial images of 40 cm² of tissue in less than 24 hours.
Learn more about the G4X Spatial Sequencer: singulargenomi...

[@maxsimpson4446]

You guys should post more on KZbin and all socials! Great stuff.